US Broker Ratings

Sarepta Therapeutics, Inc. (SRPT)

⚠️ No article content returned.

..

Novartis AG (NVS) Stock Analysis: Insights into the Healthcare Giant’s Growth and Dividend Appeal

Novartis AG (NYSE: NVS) stands as a powerhouse in the global pharmaceutical industry, commanding a substantial market presence with a market capitalization of $239.03 billion. Headquartered in Basel, Switzerland, Novartis..

Smith & Nephew SNATS, Inc. (SNN): Investor Outlook Reveals 9.48% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, stands as a noteworthy consideration for investors focusing on the medical devices industry. With a market..

DexCom, Inc. (DXCM) Stock Analysis: Evaluating a 18.25% Potential Upside in the Healthcare Sector

DexCom, Inc. (DXCM), a leader in the medical devices space, commands a significant position in the healthcare sector with a market capitalization of $32.69 billion. Headquartered in San Diego, California,..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 70% Upside Potential with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a dynamic player in the biotechnology sector, presents a compelling opportunity for investors seeking substantial upside potential. With its headquarters in Dublin, Ireland, Jazz Pharmaceuticals..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 14.62% Potential Upside with Robust Dividend Yield

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a key player in the healthcare sector’s medical devices industry, offers investors a compelling scenario characterized by a mixture of stability and potential growth...

Merck & Company, Inc. (MRK) Stock Analysis: Strong Dividend Yield and Potential Upside Attract Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, consistently commands attention from investors due to its robust portfolio and strategic partnerships. Operating primarily in the pharmaceutical..

Investor Outlook: Hologic, Inc. (HOLX) Shows Resilience with Strong Cash Flow and Modest Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers intriguing prospects for investors. With a market capitalization of $14.65..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a 28% Upside Potential Amidst Strategic Partnerships

Biogen Inc. (NASDAQ: BIIB) stands prominently within the healthcare sector, specifically among drug manufacturers. With a market capitalization of $19.67 billion, Biogen is a formidable player in the realm of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 22.71% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a noteworthy entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $7 billion, Bio-Rad is a..

Guardant Health, Inc. (GH) Stock Analysis: A Diagnostic Innovator with 18.73% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology sector, stands out in the healthcare landscape with its robust portfolio of cutting-edge diagnostic solutions. With a market capitalization..

Medtronic plc (MDT) Stock Analysis: Unpacking Its 7.4% Potential Upside for Investors

Medtronic plc (NYSE: MDT), a leading player in the medical devices industry, offers an intriguing investment opportunity with a potential upside of 7.4%, as suggested by analyst ratings. With a..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on Its 62% Revenue Growth and 62% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a key player in the healthcare sector, is making significant strides in the biotechnology industry, focusing on innovative treatments for central nervous system disorders. With..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 23% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable attention from investors due to its solid fundamentals and potential..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Promising Biotech with 250% Potential Upside

Investors with an eye on the biotechnology sector may want to take a closer look at Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company with a promising pipeline targeting..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring a Promising 38.77% Upside Amid Biotech Innovations

Summit Therapeutics Inc. (SMMT), a U.S.-based biopharmaceutical company, has recently caught the eye of investors seeking opportunities within the healthcare sector. With an impressive market capitalization of $18.57 billion, Summit..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Its 6.5% Potential Upside and Robust Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD), a formidable player in the healthcare sector, continues to capture the attention of investors with its strong market position and promising future prospects. With a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Giant with a 14.72% Potential Upside

The Ensign Group, Inc. (ENSG), a prominent player in the U.S. healthcare sector, is making waves with its impressive growth metrics and a notable potential upside of 14.72%, according to..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with 22% Upside Potential

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, continues to capture investor interest with its formidable presence in the Diagnostics & Research industry. Headquartered in Waltham, Massachusetts,..

Molina Healthcare Inc (MOH) Stock Report: Analyzing a 62% Potential Upside for Investors

Molina Healthcare Inc (NYSE: MOH) stands out in the healthcare plans sector with its expansive coverage of low-income families and individuals through Medicaid and Medicare programs. Headquartered in Long Beach,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds